NCT05328856 Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being
| NCT ID | NCT05328856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | General Population |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-05-25 |
| Primary Completion | 2025-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2022-05-25 with a primary completion date of 2025-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.
Eligibility Criteria
Inclusion Criteria: * Female and male patients between 18 and 70 years of age Exclusion Criteria: * Bad general condition * Serious acute or chronic comorbidity * Pregnancy and breast feeding period/ in the next 6 months * Participation in a clinical trial within the last 3 months before enrollment * Simultaneous participation in another clinical trial * Raynaud's disease or cold agglutinin disease * Severe mental illness * Insufficiently treated dermatological diseases (e.g. neurodermatitis, psoriasis) * Non-compatible sanitary shower or bath devices
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05328856 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying General Population. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05328856 currently recruiting?
Yes, NCT05328856 is actively recruiting participants. Contact the research team at miriam.roesner@immanuelalbertinen.de for enrollment information.
Where is the NCT05328856 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT05328856 clinical trial?
NCT05328856 is sponsored by Charite University, Berlin, Germany. The trial plans to enroll 50 participants.